These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8422091)
41. Progestins and growth hormone excess in the dog. Selman PJ; Mol JA; Rutteman GR; Rijnberk A Acta Endocrinol (Copenh); 1991; 125 Suppl 1():42-7. PubMed ID: 1839344 [TBL] [Abstract][Full Text] [Related]
42. Blunted growth hormone responses to clonidine in adolescent girls with early anorexia nervosa. Evidence for an early hypothalamic defect. Nussbaum MP; Blethen SL; Chasalow FI; Jacobson MS; Shenker IR; Feldman J J Adolesc Health Care; 1990 Mar; 11(2):145-8. PubMed ID: 2318712 [TBL] [Abstract][Full Text] [Related]
43. The growth hormone response to clonidine in acute and remitted depressed male patients. Siever LJ; Trestman RL; Coccaro EF; Bernstein D; Gabriel SM; Owen K; Moran M; Lawrence T; Rosenthal J; Horvath TB Neuropsychopharmacology; 1992 May; 6(3):165-77. PubMed ID: 1599607 [TBL] [Abstract][Full Text] [Related]
44. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. De Marinis L; Folli G; D'Amico C; Mancini A; Sambo P; Tofani A; Oradei A; Barbarino A J Clin Endocrinol Metab; 1988 Mar; 66(3):598-604. PubMed ID: 3127419 [TBL] [Abstract][Full Text] [Related]
45. In vivo studies with growth hormone (GH)-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis. Cella SG; Locatelli V; De Gennaro V; Pellini C; Pintor C; Müller EE Endocrinology; 1986 Sep; 119(3):1164-70. PubMed ID: 3089765 [TBL] [Abstract][Full Text] [Related]
46. Clonidine challenge in childhood anxiety disorder. Sallee FR; Richman H; Sethuraman G; Dougherty D; Sine L; Altman-Hamamdzic S J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):655-62. PubMed ID: 9628086 [TBL] [Abstract][Full Text] [Related]
47. Impaired growth hormone response to clonidine in obesity. Altomonte L; Zoli A; Mirone L; Berchicci M; Travaglini R; Pellicano P; Greco AV Exp Clin Endocrinol; 1988 Dec; 92(2):231-4. PubMed ID: 3243343 [TBL] [Abstract][Full Text] [Related]
48. Plasma growth hormone responses to growth hormone-releasing hormone in children of short stature. Tsai WY; Chen SH; Lee JS Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):801-5. PubMed ID: 2512368 [TBL] [Abstract][Full Text] [Related]
49. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine. Coplan JD; Pine DS; Papp LA; Gorman JM Psychopharmacol Bull; 1997; 33(2):193-204. PubMed ID: 9230631 [No Abstract] [Full Text] [Related]
50. Growth hormone response to clonidine in the nervous pointer dog model of anxiety. Uhde TW; Malloy LC; Benson BB Anxiety; 1994; 1(2):45-9. PubMed ID: 9160547 [TBL] [Abstract][Full Text] [Related]
52. A review of GHRH stimulation test in psychiatry. Skare SS; Dysken MW; Billington CJ Biol Psychiatry; 1994 Aug; 36(4):249-65. PubMed ID: 7986890 [TBL] [Abstract][Full Text] [Related]
53. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Kellner M; Yassouridis A; Jahn H; Wiedemann K Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081 [TBL] [Abstract][Full Text] [Related]
54. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Siever LJ; Uhde TW; Silberman EK; Jimerson DC; Aloi JA; Post RM; Murphy DL Psychiatry Res; 1982 Apr; 6(2):171-83. PubMed ID: 6283576 [TBL] [Abstract][Full Text] [Related]
56. Effect of sleep deprivation on the growth hormone response to the alpha-3 adrenergic receptor agonist, clonidine, in normal subjects. Lal S; Thavundayil JX; Krishnan B; Nair NP; Schwartz G; Kiely ME; Guyda H J Neural Transm (Vienna); 1997; 104(2-3):291-8. PubMed ID: 9203090 [TBL] [Abstract][Full Text] [Related]
57. Clonidine-induced growth hormone secretion in elderly patients with senile dementia of the Alzheimer type and major depressive disorder. Gilles C; Ryckaert P; De Mol J; de Maertelaere V; Mendlewicz J Psychiatry Res; 1989 Mar; 27(3):277-86. PubMed ID: 2710869 [TBL] [Abstract][Full Text] [Related]
58. Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness. Amsterdam JD; Maislin G Biol Psychiatry; 1990 Aug; 28(4):308-14. PubMed ID: 2204433 [TBL] [Abstract][Full Text] [Related]
59. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Ansseau M; Von Frenckell R; Cerfontaine JL; Papart P; Franck G; Timsit-Berthier M; Geenen V; Legros JJ Br J Psychiatry; 1988 Jul; 153():65-71. PubMed ID: 3224252 [TBL] [Abstract][Full Text] [Related]
60. Specificity of the pyridostigmine/growth hormone challenge in the diagnosis of depression. Cooney JM; Lucey JV; O'Keane V; Dinan TG Biol Psychiatry; 1997 Nov; 42(9):827-33. PubMed ID: 9347132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]